Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls

Identifieur interne : 005849 ( Main/Exploration ); précédent : 005848; suivant : 005850

Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls

Auteurs : Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. C. Costa [Royaume-Uni]

Source :

RBID : ISTEX:84AB60CC8D1941B48863612D67182B24DC5DC68C

English descriptors

Abstract

Corticobasal degeneration (CBD) is a rare syndrome characterised by an asymmetrical rigidity with localised cortical signs, particularly apraxia. Using positron emission tomography, abnormal patterns of cortical metabolism have recently been shown. We have studied patterns of regional cerebral blood flow (rCBF) using single photon emission tomography, with the tracer 99Technetium hexamethylpropylenamine (HMPAO), in subjects with CBD. In subjects with CBD, compared with 12 age‐matched normal controls, in the clinically more affected hemisphere a characteristic pattern was found with significant reductions in HMPAO uptake in the posterior frontal cortex (by 11.5%), and in the superior, inferior, anterior, and posterior parietal cortex (by 12.2, 12.9, 12.9, and 9.7, respectively). Reduced uptake was also found in the caudate (9.3%), putamen (9.7%), and thalamus (8.6%). In contrast, HMPAO uptake in the temporal and occipital cortex was normal. In comparison with 12 Parkinson's disease (PD) controls, significant reduced uptake was seen in the thalamus (9.0%), posterior frontal (8.9%), and inferior (9.9%), and anterior parietal (9.5%) cortex. A similar pattern of impaired uptake was seen in the clinically les/unaffected cerebral hemisphere in patients with CBD compared with normal controls, with a significant reduction in HMPAO uptake in the thalamus (6.8%), superior parietal (9.6%) and anterior parietal (7.6%), and posterior parietal (7.3%) cortex. This implies that the disease process is bilateral even in those cases with clinically unilateral disease. This widely available technique may be useful in the early diagnosis of CBD and in differentiation from other extrapyramidal disorders.

Url:
DOI: 10.1002/mds.870100208


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls</title>
<author>
<name sortKey="Markus" sort="Markus" uniqKey="Markus" last="Markus">Markus</name>
</author>
<author>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
<author>
<name sortKey="Lennox, G" sort="Lennox, G" uniqKey="Lennox G" first="G." last="Lennox">G. Lennox</name>
</author>
<author>
<name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name>
</author>
<author>
<name sortKey="Costa, D C" sort="Costa, D C" uniqKey="Costa D" first="D. C." last="Costa">D. C. Costa</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:84AB60CC8D1941B48863612D67182B24DC5DC68C</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1002/mds.870100208</idno>
<idno type="url">https://api.istex.fr/document/84AB60CC8D1941B48863612D67182B24DC5DC68C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000292</idno>
<idno type="wicri:Area/Istex/Curation">000292</idno>
<idno type="wicri:Area/Istex/Checkpoint">003C80</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Markus:patterns:of:regional</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7753060</idno>
<idno type="wicri:Area/PubMed/Corpus">004A12</idno>
<idno type="wicri:Area/PubMed/Curation">004A12</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004941</idno>
<idno type="wicri:Area/Ncbi/Merge">004750</idno>
<idno type="wicri:Area/Ncbi/Curation">004750</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004750</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Markus H:patterns:of:regional</idno>
<idno type="wicri:Area/Main/Merge">008A11</idno>
<idno type="wicri:Area/Main/Curation">005849</idno>
<idno type="wicri:Area/Main/Exploration">005849</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls</title>
<author>
<name sortKey="Markus" sort="Markus" uniqKey="Markus" last="Markus">Markus</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Department of Neurology, University College and Middlesex Hospitals School of Medicine, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Department of Neurology, University College and Middlesex Hospitals School of Medicine, London</wicri:cityArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
<author>
<name sortKey="Lennox, G" sort="Lennox, G" uniqKey="Lennox G" first="G." last="Lennox">G. Lennox</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>National Hospital for Neurology and Neurosurgery, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>National Hospital for Neurology and Neurosurgery, London</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Costa, D C" sort="Costa, D C" uniqKey="Costa D" first="D. C." last="Costa">D. C. Costa</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Institute of Nuclear Medicine, University College and Middlesex Hospitals School of Medicine, London</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1995-03">1995-03</date>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="179">179</biblScope>
<biblScope unit="page" to="187">187</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">84AB60CC8D1941B48863612D67182B24DC5DC68C</idno>
<idno type="DOI">10.1002/mds.870100208</idno>
<idno type="ArticleID">MDS870100208</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age Factors</term>
<term>Aged</term>
<term>Basal Ganglia Diseases (diagnosis)</term>
<term>Basal Ganglia Diseases (physiopathology)</term>
<term>Blood Flow Velocity</term>
<term>Brain (physiopathology)</term>
<term>Cerebral blood flow</term>
<term>Corticobasal degeneration</term>
<term>Female</term>
<term>Functional Laterality</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson's disease</term>
<term>Single photon emission tomography</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Basal Ganglia Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Basal Ganglia Diseases</term>
<term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Age Factors</term>
<term>Aged</term>
<term>Blood Flow Velocity</term>
<term>Female</term>
<term>Functional Laterality</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Corticobasal degeneration (CBD) is a rare syndrome characterised by an asymmetrical rigidity with localised cortical signs, particularly apraxia. Using positron emission tomography, abnormal patterns of cortical metabolism have recently been shown. We have studied patterns of regional cerebral blood flow (rCBF) using single photon emission tomography, with the tracer 99Technetium hexamethylpropylenamine (HMPAO), in subjects with CBD. In subjects with CBD, compared with 12 age‐matched normal controls, in the clinically more affected hemisphere a characteristic pattern was found with significant reductions in HMPAO uptake in the posterior frontal cortex (by 11.5%), and in the superior, inferior, anterior, and posterior parietal cortex (by 12.2, 12.9, 12.9, and 9.7, respectively). Reduced uptake was also found in the caudate (9.3%), putamen (9.7%), and thalamus (8.6%). In contrast, HMPAO uptake in the temporal and occipital cortex was normal. In comparison with 12 Parkinson's disease (PD) controls, significant reduced uptake was seen in the thalamus (9.0%), posterior frontal (8.9%), and inferior (9.9%), and anterior parietal (9.5%) cortex. A similar pattern of impaired uptake was seen in the clinically les/unaffected cerebral hemisphere in patients with CBD compared with normal controls, with a significant reduction in HMPAO uptake in the thalamus (6.8%), superior parietal (9.6%) and anterior parietal (7.6%), and posterior parietal (7.3%) cortex. This implies that the disease process is bilateral even in those cases with clinically unilateral disease. This widely available technique may be useful in the early diagnosis of CBD and in differentiation from other extrapyramidal disorders.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
<orgName>
<li>National Hospital for Neurology and Neurosurgery</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Markus" sort="Markus" uniqKey="Markus" last="Markus">Markus</name>
</region>
<name sortKey="Costa, D C" sort="Costa, D C" uniqKey="Costa D" first="D. C." last="Costa">D. C. Costa</name>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">Andrew Lees (neurologue)</name>
<name sortKey="Lennox, G" sort="Lennox, G" uniqKey="Lennox G" first="G." last="Lennox">G. Lennox</name>
<name sortKey="Marsden, C D" sort="Marsden, C D" uniqKey="Marsden C" first="C. D." last="Marsden">C. D. Marsden</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005849 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005849 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:84AB60CC8D1941B48863612D67182B24DC5DC68C
   |texte=   Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024